Version 1
: Received: 26 September 2024 / Approved: 26 September 2024 / Online: 26 September 2024 (16:44:59 CEST)
How to cite:
Li, B.; Cao, P.; Xu, W.; Zhang, L. Eczematous Adverse Drug Reaction after Selpercatinib Treatment: Case Report. Preprints2024, 2024092145. https://doi.org/10.20944/preprints202409.2145.v1
Li, B.; Cao, P.; Xu, W.; Zhang, L. Eczematous Adverse Drug Reaction after Selpercatinib Treatment: Case Report. Preprints 2024, 2024092145. https://doi.org/10.20944/preprints202409.2145.v1
Li, B.; Cao, P.; Xu, W.; Zhang, L. Eczematous Adverse Drug Reaction after Selpercatinib Treatment: Case Report. Preprints2024, 2024092145. https://doi.org/10.20944/preprints202409.2145.v1
APA Style
Li, B., Cao, P., Xu, W., & Zhang, L. (2024). Eczematous Adverse Drug Reaction after Selpercatinib Treatment: Case Report. Preprints. https://doi.org/10.20944/preprints202409.2145.v1
Chicago/Turabian Style
Li, B., Wenjing Xu and Litao Zhang. 2024 "Eczematous Adverse Drug Reaction after Selpercatinib Treatment: Case Report" Preprints. https://doi.org/10.20944/preprints202409.2145.v1
Abstract
This study reports a 50-year-old patient presented with eczematous drug-eruption induced by selpercatinib after the treatment of non-small cell lung cancer (NSCLC). The patient has symmetric erythematous papules and plaques all over the body with dry, scaly skin accompanied by severe pruritus and visible scarring. After systemic treatment with glucocorticoids, the skin lesions of the patient were well reduced. Currently, the medical literature on the incidence of selpercatinib-induced cutaneous eczematous reactions and their clinical management is scarce. Therefore, this study provides novel evidence for the treatment of selpercatinib-induced cutaneous eczematous reactions.
Keywords
eczematous reaction; adverse drug reaction; selective RET inhibitor; Selpercatinib; glucocorticoid
Subject
Medicine and Pharmacology, Dermatology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.